ID   ADA15_RAT               Reviewed;         864 AA.
AC   Q9QYV0; Q6P779;
DT   01-JUN-2001, integrated into UniProtKB/Swiss-Prot.
DT   13-JUL-2010, sequence version 2.
DT   02-OCT-2024, entry version 172.
DE   RecName: Full=Disintegrin and metalloproteinase domain-containing protein 15;
DE            Short=ADAM 15;
DE            EC=3.4.24.-;
DE   AltName: Full=CRII-7;
DE   AltName: Full=Metalloprotease RGD disintegrin protein;
DE   AltName: Full=Metalloproteinase-like, disintegrin-like, and cysteine-rich protein 15;
DE            Short=MDC-15;
DE   AltName: Full=Metargidin;
DE   Flags: Precursor;
GN   Name=Adam15; Synonyms=Mdc15;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Sciatic nerve;
RX   PubMed=11102971;
RX   DOI=10.1002/1098-1136(200012)32:3<313::aid-glia100>3.0.co;2-g;
RA   Bosse F., Petzold G., Greiner-Petter R., Pippirs U., Gillen C.,
RA   Mueller H.-W.;
RT   "Cellular localization of the disintegrin CRII-7/rMDC15 mRNA in rat PNS and
RT   CNS and regulated expression in postnatal development and after nerve
RT   injury.";
RL   Glia 32:313-327(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Prostate;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Active metalloproteinase with gelatinolytic and
CC       collagenolytic activity. Plays a role in the wound healing process.
CC       Mediates both heterotypic intraepithelial cell/T-cell interactions and
CC       homotypic T-cell aggregation. Inhibits beta-1 integrin-mediated cell
CC       adhesion and migration of airway smooth muscle cells. Suppresses cell
CC       motility on or towards fibronectin possibly by driving alpha-v/beta-1
CC       integrin (ITAGV-ITGB1) cell surface expression via ERK1/2 inactivation.
CC       Cleaves E-cadherin in response to growth factor deprivation. Plays a
CC       role in glomerular cell migration. Plays a role in pathological
CC       neovascularization. May play a role in cartilage remodeling. May be
CC       proteolytically processed, during sperm epididymal maturation and the
CC       acrosome reaction. May play a role in sperm-egg binding through its
CC       disintegrin domain (By similarity). {ECO:0000250}.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000305};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000305};
CC   -!- SUBUNIT: Interacts with ITAGV-ITGB3 (vitronectin receptor). Interacts
CC       with SH3GL2 and SNX9; this interaction occurs preferentially with
CC       ADAM15 precursor, rather than the processed form, suggesting it occurs
CC       in a secretory pathway compartment prior to the medial Golgi (By
CC       similarity). Interacts with ITAG9-ITGB1. Interacts specifically with
CC       Src family protein-tyrosine kinases (PTKs). Interacts with SH3PXD2A.
CC       Interacts with ITAGV-ITGB1. Interacts with GRB2, HCK, ITSN1, ITSN2,
CC       LYN, MAPK1, MAPK3, NCF1, NCK1, nephrocystin, PTK6, SNX33, LCK and SRC
CC       (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Endomembrane system {ECO:0000250}; Single-pass
CC       type I membrane protein {ECO:0000250}. Cell junction, adherens junction
CC       {ECO:0000250}. Cell projection, cilium, flagellum {ECO:0000250}.
CC       Cytoplasmic vesicle, secretory vesicle, acrosome {ECO:0000250}.
CC       Note=The majority of the protein is localized in a perinuclear
CC       compartment which may correspond to the trans-Golgi network or the late
CC       endosome. The pro-protein is the major detectable form on the cell
CC       surface, whereas the majority of the protein in the cell is processed
CC       (By similarity). {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9QYV0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9QYV0-2; Sequence=VSP_039534;
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in brain, spinal cord,
CC       sciatic nerve and lung. Expressed at lower levels in all other tissues.
CC       In the peripheral nervous system, expressed predominantly by Schwann
CC       cells. In the central nervous system, preferentially expressed by
CC       neuronal cells.
CC   -!- INDUCTION: In response to sciatic nerve injury.
CC   -!- DOMAIN: The cytoplasmic domain is required for SH3GL2- and SNX9-
CC       binding. {ECO:0000250}.
CC   -!- DOMAIN: Disintegrin domain binds to integrin alphaV-beta3.
CC       {ECO:0000250}.
CC   -!- DOMAIN: The conserved cysteine present in the cysteine-switch motif
CC       binds the catalytic zinc ion, thus inhibiting the enzyme. The
CC       dissociation of the cysteine from the zinc ion upon the activation-
CC       peptide release activates the enzyme.
CC   -!- PTM: The precursor is cleaved by a furin endopeptidase. {ECO:0000250}.
CC   -!- PTM: Phosphorylation increases association with PTKs. {ECO:0000250}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ251198; CAB61762.1; -; mRNA.
DR   EMBL; BC061796; AAH61796.1; -; mRNA.
DR   RefSeq; NP_064704.1; NM_020308.1. [Q9QYV0-2]
DR   RefSeq; XP_006232804.1; XM_006232742.3.
DR   AlphaFoldDB; Q9QYV0; -.
DR   SMR; Q9QYV0; -.
DR   BioGRID; 248604; 1.
DR   STRING; 10116.ENSRNOP00000039351; -.
DR   ChEMBL; CHEMBL4802019; -.
DR   MEROPS; M12.215; -.
DR   GlyCosmos; Q9QYV0; 6 sites, No reported glycans.
DR   GlyGen; Q9QYV0; 6 sites.
DR   PhosphoSitePlus; Q9QYV0; -.
DR   SwissPalm; Q9QYV0; -.
DR   PaxDb; 10116-ENSRNOP00000039351; -.
DR   Ensembl; ENSRNOT00000027970.5; ENSRNOP00000027970.2; ENSRNOG00000020590.9. [Q9QYV0-2]
DR   Ensembl; ENSRNOT00000050868.5; ENSRNOP00000039351.2; ENSRNOG00000020590.9. [Q9QYV0-1]
DR   GeneID; 57025; -.
DR   KEGG; rno:57025; -.
DR   UCSC; RGD:620402; rat. [Q9QYV0-1]
DR   AGR; RGD:620402; -.
DR   CTD; 8751; -.
DR   RGD; 620402; Adam15.
DR   eggNOG; KOG3607; Eukaryota.
DR   GeneTree; ENSGT00940000159822; -.
DR   HOGENOM; CLU_012714_7_2_1; -.
DR   InParanoid; Q9QYV0; -.
DR   OMA; HADSWAS; -.
DR   OrthoDB; 5406290at2759; -.
DR   PhylomeDB; Q9QYV0; -.
DR   TreeFam; TF314733; -.
DR   Reactome; R-RNO-1474228; Degradation of the extracellular matrix.
DR   Reactome; R-RNO-8941237; Invadopodia formation.
DR   PRO; PR:Q9QYV0; -.
DR   Proteomes; UP000002494; Chromosome 2.
DR   Bgee; ENSRNOG00000020590; Expressed in esophagus and 19 other cell types or tissues.
DR   GO; GO:0001669; C:acrosomal vesicle; IEA:UniProtKB-SubCell.
DR   GO; GO:0005912; C:adherens junction; IEA:UniProtKB-SubCell.
DR   GO; GO:0009986; C:cell surface; ISO:RGD.
DR   GO; GO:0070062; C:extracellular exosome; ISO:RGD.
DR   GO; GO:0005615; C:extracellular space; IBA:GO_Central.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-KW.
DR   GO; GO:0031514; C:motile cilium; IEA:UniProtKB-SubCell.
DR   GO; GO:0034987; F:immunoglobulin receptor binding; ISO:RGD.
DR   GO; GO:0005178; F:integrin binding; ISO:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004222; F:metalloendopeptidase activity; IBA:GO_Central.
DR   GO; GO:0008237; F:metallopeptidase activity; ISO:RGD.
DR   GO; GO:0017124; F:SH3 domain binding; ISO:RGD.
DR   GO; GO:0001525; P:angiogenesis; IEA:UniProtKB-KW.
DR   GO; GO:0060317; P:cardiac epithelial to mesenchymal transition; ISO:RGD.
DR   GO; GO:0098609; P:cell-cell adhesion; TAS:RGD.
DR   GO; GO:1904628; P:cellular response to phorbol 13-acetate 12-myristate; ISO:RGD.
DR   GO; GO:0030574; P:collagen catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0002418; P:immune response to tumor cell; ISO:RGD.
DR   GO; GO:0045087; P:innate immune response; ISO:RGD.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; ISO:RGD.
DR   GO; GO:0008584; P:male gonad development; IEP:RGD.
DR   GO; GO:0030308; P:negative regulation of cell growth; ISO:RGD.
DR   GO; GO:0030336; P:negative regulation of cell migration; ISO:RGD.
DR   GO; GO:0001953; P:negative regulation of cell-matrix adhesion; ISO:RGD.
DR   GO; GO:0006508; P:proteolysis; IBA:GO_Central.
DR   GO; GO:1990910; P:response to hypobaric hypoxia; IEP:RGD.
DR   GO; GO:0042246; P:tissue regeneration; IEP:RGD.
DR   CDD; cd04269; ZnMc_adamalysin_II_like; 1.
DR   Gene3D; 3.40.390.10; Collagenase (Catalytic Domain); 1.
DR   Gene3D; 4.10.70.10; Disintegrin domain; 1.
DR   Gene3D; 2.60.120.260; Galactose-binding domain-like; 1.
DR   InterPro; IPR006586; ADAM_Cys-rich.
DR   InterPro; IPR001762; Disintegrin_dom.
DR   InterPro; IPR036436; Disintegrin_dom_sf.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR024079; MetalloPept_cat_dom_sf.
DR   InterPro; IPR001590; Peptidase_M12B.
DR   InterPro; IPR002870; Peptidase_M12B_N.
DR   InterPro; IPR034027; Reprolysin_adamalysin.
DR   PANTHER; PTHR11905; ADAM A DISINTEGRIN AND METALLOPROTEASE DOMAIN; 1.
DR   PANTHER; PTHR11905:SF130; DISINTEGRIN AND METALLOPROTEINASE DOMAIN-CONTAINING PROTEIN 15; 1.
DR   Pfam; PF08516; ADAM_CR; 1.
DR   Pfam; PF00200; Disintegrin; 1.
DR   Pfam; PF01562; Pep_M12B_propep; 1.
DR   Pfam; PF01421; Reprolysin; 1.
DR   SMART; SM00608; ACR; 1.
DR   SMART; SM00050; DISIN; 1.
DR   SUPFAM; SSF57552; Blood coagulation inhibitor (disintegrin); 1.
DR   SUPFAM; SSF55486; Metalloproteases ('zincins'), catalytic domain; 1.
DR   PROSITE; PS50215; ADAM_MEPRO; 1.
DR   PROSITE; PS50214; DISINTEGRIN_2; 1.
DR   PROSITE; PS01186; EGF_2; 1.
DR   PROSITE; PS50026; EGF_3; 1.
DR   PROSITE; PS00142; ZINC_PROTEASE; 1.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Angiogenesis; Cell adhesion; Cell junction;
KW   Cell projection; Cilium; Cleavage on pair of basic residues;
KW   Collagen degradation; Cytoplasmic vesicle; Disulfide bond; EGF-like domain;
KW   Flagellum; Glycoprotein; Hydrolase; Membrane; Metal-binding;
KW   Metalloprotease; Phosphoprotein; Protease; Reference proteome; SH3-binding;
KW   Signal; Transmembrane; Transmembrane helix; Zinc; Zymogen.
FT   SIGNAL          1..17
FT                   /evidence="ECO:0000255"
FT   PROPEP          18..208
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000029086"
FT   CHAIN           209..864
FT                   /note="Disintegrin and metalloproteinase domain-containing
FT                   protein 15"
FT                   /id="PRO_0000029087"
FT   TOPO_DOM        209..698
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        699..719
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        720..864
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          215..416
FT                   /note="Peptidase M12B"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00276"
FT   DOMAIN          423..510
FT                   /note="Disintegrin"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00068"
FT   DOMAIN          659..687
FT                   /note="EGF-like"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   REGION          17..49
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          738..864
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           178..185
FT                   /note="Cysteine switch"
FT                   /evidence="ECO:0000250"
FT   MOTIF           816..822
FT                   /note="SH3-binding"
FT                   /evidence="ECO:0000255"
FT   MOTIF           851..857
FT                   /note="SH3-binding"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        27..49
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        796..834
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        849..864
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        351
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00276,
FT                   ECO:0000255|PROSITE-ProRule:PRU10095"
FT   BINDING         180
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /note="in inhibited form"
FT                   /evidence="ECO:0000250"
FT   BINDING         350
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255"
FT   BINDING         354
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255"
FT   BINDING         360
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         717
FT                   /note="Phosphotyrosine; by HCK and LCK"
FT                   /evidence="ECO:0000250|UniProtKB:Q13444"
FT   MOD_RES         737
FT                   /note="Phosphotyrosine; by HCK and LCK"
FT                   /evidence="ECO:0000250|UniProtKB:Q13444"
FT   CARBOHYD        57
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        239
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        391
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        394
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        608
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        613
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        325..411
FT                   /evidence="ECO:0000250"
FT   DISULFID        367..395
FT                   /evidence="ECO:0000250"
FT   DISULFID        369..378
FT                   /evidence="ECO:0000250"
FT   DISULFID        482..502
FT                   /evidence="ECO:0000250"
FT   DISULFID        659..669
FT                   /evidence="ECO:0000250"
FT   DISULFID        663..675
FT                   /evidence="ECO:0000250"
FT   DISULFID        677..686
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         762..809
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11102971"
FT                   /id="VSP_039534"
FT   CONFLICT        202
FT                   /note="H -> R (in Ref. 2; AAH61796)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   864 AA;  93308 MW;  5D46466922A89196 CRC64;
     MRLALLWALG LLGAGSPRPS PPLPNIGGTE EEQQASPERT QSRSLENQVV QDSPPINLTE
     VLQTGLPETL RIGLELDGEN HILELQQNRD LVPGRPTLVW YQPDGTRMVS EGHSLENCCY
     RGRVQGRPSS WVSLCACSGI RGLVVLSPER SYTLELGPGD LQRPLIVSRI QDLLLPGHTC
     APSWHAFVPT EAAPDLLLEQ HHLRRLKRDV VTETKIVELV IVADNSEVRK YPDFQQLLNR
     TLEVALLLDT FFQPLNVRVA LVGLEAWTQR DLIEMSSNPA VLLDNFLRWR RTDLLPRLPH
     DSAQLVTVTS FSGPMVGMAI QNSICSPDFS GGVNMDHSTS ILGVASSIAH ELGHSLGLDH
     DSPGNSCPCP GPAPAKSCIM EASTDFLPGL NFSNCSRWAL EKALLDGMGS CLFEWPPSRA
     PMSSLCGNMF VDPGEQCDCG FPDECTDPCC DYFTCQLRPG AQCASDGPCC QNCKLQPAGW
     QCRLPTDDCD LPEFCLGDSS QCPPDIRLGD GEPCASGEAV CMHGRCASYT RQCQSLWGPG
     AQPAAPLCLQ TANTRGNAFG SCGRSPSGSY MPCNLRDAIC GQLQCQWGRN QPLLGSVQDQ
     LSEVLEANGT QLNCSWVDLD LGNDVAQPLL ALPGTACGPG LVCIGHRCQP VDLLGAQECR
     SKCHGHGVCD SSRHCHCDEG WAPPDCMTQL RATSSLTTGL LLSLLLLLVL VLLGASYWYR
     ARLHQRLCQL KGSSCQYRAA QSGPPERPGP PQRAQQMPGT KQANVSFPVP PSRPLPPNPV
     PKKLQAELAD RSNPPTRPLP ADPVVWRPKP QGPTKPPPPR KPLPANPQGR PPLGDLPGPG
     DGSLQLVVPS RPAPPPPAAS SLYL
//
